The Clorox Co (CLX.N)
83.80USD
1 Jul 2013
$0.66 (+0.79%)
$83.14
$83.53
$84.15
$83.19
186,672
237,419
$90.09
$69.71
CLX.N
About
Overall
| Beta: | 0.36 |
| Market Cap (Mil.): | $11,033.37 |
| Shares Outstanding (Mil.): | 131.66 |
| Dividend: | 0.71 |
| Yield (%): | 3.39 |
Financials
| CLX.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.63 | 44.12 | 37.16 |
| EPS (TTM): | 4.27 | -- | -- |
| ROI: | 20.62 | 91.21 | 64.31 |
| ROE: | 2,452.17 | 99.74 | 70.34 |
Clorox Q3 profit tops estimates, but sales miss
- Clorox Co , the consumer products maker, reported a better-than-expected third-quarter profit on Wednesday, boosted by cost cuts and price increases, but sales missed estimates.
UPDATE 1-Clorox Q3 profit tops estimates, but sales miss
May 1 - Clorox Co, the consumer products maker, reported a better-than-expected third-quarter profit on Wednesday, boosted by cost cuts and price increases, but sales missed estimates.
Cost cuts, price increases help Clorox profit top estimates
May 1 - Consumer products maker Clorox Co reported on Wednesday a better-than-expected profit for the third quarter, boosted by cost cuts and price increases.
Clorox soundly beats estimates on strong sales
- Clorox Co quarterly profit soundly beat analysts' estimates as a severe flu season boosted sales of disinfecting wipes, and results were helped by a new concentrated version of its namesake bleach.
UPDATE 1-Clorox soundly beats estimates on strong sales
Feb 4 - Clorox Co quarterly profit soundly beat analysts' estimates as a severe flu season boosted sales of disinfecting wipes, and results were helped by a new concentrated version of its namesake bleach.
Clorox profit up as flu season boosts sales of wipes
Feb 4 - Clorox Co posted higher quarterly profit, as a severe flu season boosted sales of disinfecting wipes, and as sales were also helped by a new concentrated version of its namesake bleach.
Competitors
| Price | Change | |
|---|---|---|
| The Procter & Gamble Company (PG.N) | $78.02 | +1.03 |
| Unilever N.V. (UNc.AS) | €30.23 | -0.13 |
| Unilever N.V. (UNIA.AS) | €30.29 | +0.08 |
| Unilever N.V. (UN_pa.AS) | -- | -- |
| Unilever N.V. (UN_p.AS) | €79.99 | 0.00 |
| Unilever N.V. (UN_pb.AS) | -- | -- |
| Unilever plc (ULVR.L) | 2,664.00p | -11.00 |
| Kimberly Clark Corp (KMB.N) | $97.17 | +0.03 |
| Colgate-Palmolive Company (CL.N) | $57.95 | +0.66 |
| Fresenius Medical Care AG & Co. KGaA (FMEG.DE) | €49.83 | -4.61 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (CLX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
